Search Results for: MARKET BRIEF The Market for


March 29, 2016

DRUG DEVELOPMENT – Don’t Overlook Key Preclinical Research March 29, 2016

Robert Wenslow, PhD, and Ann Newman, PhD, believe too often, drug discovery scientists, material scientists, and formulation specialists work in silos throughout the drug discovery process. Better integration of their efforts can reduce drug development schedules, risk, and overall costs that provide direct competitive business advantages.